ASX:ALAPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals

AROVELLA THERAPEUTICS ORD

$0.074

$0.001 (0.67%)

Day Range

$0.074 - $0.075

52 Week Range

$0.065 - $0.125

Volume

217.36K

Avg Volume (10D)

1.21M

Market Cap

$89.45M

Price Chart

Market Statistics

Open$0.074

Previous Close$0.075

Day High$0.075

Day Low$0.074

52 Week High$0.125

52 Week Low$0.065

Valuation

Market Cap89.45M

Shares Outstanding1.21B

Price to Book4.76

Trading Activity

Volume217.36K

Value Traded16.12K

Bid$0.072 × 905,097

Ask$0.074 × 19,158

Performance

1 Day0.00%

5 Day0.00%

13 Week-19.35%

52 Week-9.64%

YTD-19.35%

Technical Indicators

RSI (14)47.79

50-Day SMA$0.075

200-Day SMA$0.085

Arovella Therapeutics confirms anti-tumour effect of lead drug ALA-101 in treating certain cancers

Arovella Therapeutics (ASX: ALA) has presented new data at the American Association for Cancer Research annual meeting relating to lead drug ALA-101 as a novel ‘off-the-shelf’ therapy to treat CD19-expressing leukemias and lymphomas. The data presented used iNKT (invariant natural killer) cells expressing a chimeric antigen receptor (CAR) which targets the CD19 biomarker. The cells […]

1 min read

Imelda Cotton